Register for updates

 
 

Medicine & Health
RSS Feed
A Glow Stick That Detects Cancer?
Monday, May 01, 2017 11:40:00 AM

TAU researchers devise a novel probe to identify and measure microscopic cell activity


An image generated by the "glow stick" probe of cancerous cells.

Chemiluminescence, or chemical light, is the principle behind the glow sticks (also known as light sticks) used at rock concerts and as quick tools to grab when the electricity goes out. But they can also be used to diagnose diseases by identifying concentrations of biological samples. A new mechanism developed by Tel Aviv University researchers produces a 3,000-times-brighter, water-resistant chemiluminescent probe with particular application to medical and cancer diagnosis.

The research found that tweaking the electronic structure of current probes improves their inherent fluorescence. This could lead to the invention of a new single-component system with multiple applications — including the detection and measurement of cellular activity that points to certain pathologies, such as cancer. The study was recently published in ACS Central Science.


Chemical structure of the "glow stick" probe.

"Chemiluminescence is considered one of the most sensitive methods used in diagnostic testing," said Prof. Doron Shabat of TAU's School of Chemistry, who led the research. "We have developed a method to prepare highly efficient compounds that emit light upon contact with a specific protein or chemical. These compounds can be used as molecular probes to detect cancerous cells, among other applications."

Fixing a glitch

The research, conducted in collaboration with Dr. Christoph Bauer of Geneva University, repairs an energy-loss "glitch" in current chemiluminescent probes. Most systems use a mixture of one emitter molecule that detects the species of interest, and another two additional ingredients — a fluorophore and a soap-like substance called a surfactant — that amplify the signal to detectable levels. But energy is lost in the transfer process from the emitter molecule to the fluorophore, and surfactants are not biocompatible.


Light emission produced by the "glow stick" probe visible to the naked eye.

"As synthetic chemists, we knew how to link structure and function," said Prof. Shabat. "By adding two key atoms, we created a much brighter probe than those currently on the market. In addition, this particular molecule is suitable for direct use in cells."

Based on this molecule, the researchers developed sensors to detect several biologically relevant chemicals. They also used the chemiluminescent molecule to measure the activity of several enzymes and to image cells by microscopy.

"This gives us a new powerful methodology with which we can prepare highly efficient chemiluminescence sensors for the detection, imaging and analysis of various cell activities," said Prof. Shabat. The researchers are currently exploring ways of amplifying the chemiluminescence of the new probes for in vivo imaging.

The research was funded in part by the Israel Science Foundation, the Binational Science Foundation, the German Israeli Foundation, and the Israeli National Nanotechnology Initiative.

Graphics: Courtesy of Prof. Doron Shabat

 




Latest News

TAU Student Film Wows at Cannes Film Festival

Rubber Dolphin written and directed by Steve Tisch School of Film and Television graduate.

Changes to Specific MicroRNA Involved in Development of Lou Gehrig's Disease

Mechanism involving specific microRNA and muscle molecules plays role in amyotrophic lateral sclerosis, TAU researchers say.

Why Diversity Programs Promoting Women and Minorities in Management Fail

Current tools that "force-feed" diversity engender bias and rebellion, TAU and Harvard University researchers say.

Moderate Decline in Violent Attacks Against Jews, But Attacks Are Becoming More Brutal

European Jews harbor increasingly "grave concerns for their security," annual TAU Kantor Center study reports.

TAU Announces Early-Stage Venture Fund to Invest in Student Innovation

TAU Ventures similar to funds at universities such as MIT, UC Berkeley and Stanford.

How Advanced Nanotechnology Can Improve Cancer Care

TAU, Harvard University researchers discuss untapped potential of targeted nanocarriers to revolutionize cancer therapy.

Antidepressants May Prevent Hospitalization Relapses in Bipolar Depression Patients

Study finds apparent benefits of addition of adjunctive antidepressants to mood stabilizers, TAU researchers say.

Koret Foundation Funds $10 Million Collaborative Initiative between TAU, Stanford University, and UC Berkeley

Grant designed to advance breakthroughs in medical and information technology.

Eastern Mediterranean Summer Will be Two Months Longer by End of 21st Century

Climate changes will cut winter in the region by half, TAU researchers say.

Having a Sibling Makes You More Empathetic, Study Finds

Younger and older siblings uniquely contribute to each other's development of empathy, TAU researchers say.

contentSecondary
c

© 2018 American Friends of Tel Aviv University
39 Broadway, Suite 1510 | New York, NY 10006 | 212.742.9070 | info@aftau.org
Privacy policy | Tel Aviv University